Concepedia
8
Publications
233
Citations
H-Index
2019
Active since
Affiliations
Amicus Therapeutics (United States)(Current)
Hôpital du Sacré-Cœur de Montréal
University College London
Université de Montréal
Royal Free London NHS Foundation Trust
Eva Krusinska is an author at Amicus Therapeutics (United States).
Publications per year
2019–2024
Assessment of plasma lyso-Gb3 for clinical monitoring of treatment response in migalastat-treated patients with Fabry disease
Daniel G. Bichet, Johannes M. F. G. Aerts, Christiane Auray‐Blais et al. · Genetics in Medicine · 2020 · 50 citations · Full text
Treatment of Autosomal Dominant Hypocalcemia Type 1 With the Calcilytic NPSP795 (SHP635)
Mary Scott Roberts, Rachel I. Gafni, Beth A Brillante et al. · Journal of Bone and Mineral Research · 2019 · 49 citations · Full text
Long-term follow-up of renal function in patients treated with migalastat for Fabry disease
Daniel G. Bichet, Roser Torrá, Eric Wallace et al. · Molecular Genetics and Metabolism Reports · 2021 · 36 citations · Full text
Long-term multisystemic efficacy of migalastat on Fabry-associated clinical events, including renal, cardiac and cerebrovascular outcomes
Derralynn Hughes, Daniel G. Bichet, Roberto Giugliani et al. · Journal of Medical Genetics · 2022 · 34 citations · Full text
Use of the patient-reported outcomes measurement information system (PROMIS®) to assess late-onset Pompe disease severity
Melodi Harfouche, Priya S. Kishnani, Eva Krusinska et al. · Journal of Patient-Reported Outcomes · 2020 · 19 citations · Full text
Rows per page
1–5 of 8